2020
Cannabinoids
De Aquino J, Arnaout B. Cannabinoids. 2020, 153-167. DOI: 10.1007/978-3-030-33404-8_10.Peer-Reviewed Original ResearchCannabis use disorderUse of cannabinoidsPotential pharmacokinetic interactionsEffects of cannabinoidsDose-dependent effectPharmacokinetic interactionsPsychotropic medicationsRisk factorsPsychosocial treatmentsPsychiatric disordersUse disordersAddiction specialistsHealthcare providersPsychomotor functioningCannabinoidsSynthetic cannabinoidsDisordersMedicinal useMedicationsPatientsProgressionBrief Training on Medication-Assisted Treatment Improves Community Mental Health Clinicians’ Confidence and Readiness to Address Substance Use Disorders
Iheanacho T, Bommersbach T, Fuehrlein B, Arnaout B, Dike C. Brief Training on Medication-Assisted Treatment Improves Community Mental Health Clinicians’ Confidence and Readiness to Address Substance Use Disorders. Community Mental Health Journal 2020, 56: 1429-1435. PMID: 32062717, PMCID: PMC7429311, DOI: 10.1007/s10597-020-00586-8.Peer-Reviewed Original ResearchConceptsSubstance use disordersMedication-assisted treatmentCommunity mental health cliniciansMental health cliniciansHealth cliniciansPost-training questionnairesUse disordersDisease modelsRoutine practiceCliniciansFactor 1Factor 2Brief trainingDisordersSignificant changesQuestionnaireLimited awarenessTreatmentPublic sector settingsAddictionPreMedicationsPatientsLow confidenceDisease
2010
Sedative-Hypnotics and Anxiolytics
Arnaout B, Petrakis I. Sedative-Hypnotics and Anxiolytics. 2010, 511-523. DOI: 10.1007/978-1-4419-0338-9_23.Peer-Reviewed Original ResearchCentral nervous system depressantsPsychiatric adverse eventsGroup of medicationsNon-benzodiazepine hypnoticsNon-medical useAdverse eventsSexual dysfunctionSleep disordersSedative hypnoticsPsychotic manifestationsCognitive disordersTherapeutic valueGeneral medicineAnxiety disordersMedicationsDisordersAnxiolyticsDeleterious effectsAbuseHypnoticsDysfunctionBenzodiazepinesEpidemiologyIntoxicationNeurology
2008
Does a History of Alcohol Use Disorder Affect Response to Antidepressant Medication in Patients With Dysthymic Disorder?
Arnaout B, Batchelder S, Rosenthal R, Hyler S, Hellerstein D. Does a History of Alcohol Use Disorder Affect Response to Antidepressant Medication in Patients With Dysthymic Disorder? Journal Of Dual Diagnosis 2008, 4: 377-393. DOI: 10.1080/15504260802086842.Peer-Reviewed Original ResearchLifetime alcohol use disorderAlcohol use disorderDysthymic disorderUse disordersBaseline Hamilton Depression Rating ScaleHamilton Depression Rating ScaleRating ScaleWeeks of treatmentWeeks of pharmacotherapyDepression Rating ScaleHDRS-24Medication trialsAlcoholic patientsAdult outpatientsRate of responseLifetime historySecondary analysisDisordersGreater decreaseRemissionPharmacotherapyPatientsAdequate evaluationTreatmentPreliminary findingsDiagnosing co-morbid drug use in patients with alcohol use disorders.
Arnaout B, Petrakis IL. Diagnosing co-morbid drug use in patients with alcohol use disorders. Alcohol Research 2008, 31: 148-54. PMID: 23584816, PMCID: PMC3860455.Peer-Reviewed Original Research